Involvement and (Potential) Influence of Care Providers in the Enlistment Phase of the Informed Consent Process: the case of aids clinical trials

Abstract

This article draws on ethnographic field data collected during an investigation of the informed consent process and AIDS clinical trials. It describes the involvement of care providers (physicians, nurse practitioners, physician assistants) during the enlistment, or recruitment, phase of the informed consent process. It shows that sometimes care providers are involved in the receipt, evaluation and distribution of information on clinical trials through their interactions with research professionals and patients. It suggests that the involvement of care providers has the potential to influence the informed consent process. Some of the ethical and practice considerations of this are discussed.

Keywords

AIDS care providers clinical trials human participants informed consent nurses researchers

Get full access to this article

View all access options for this article.

References

Katz J. The silent world of doctor and patient. New York: Free Press , 1984.

Berg JW , Appelbaum PS , Lidz CW , Parker LS. Informed consent: legal theory and clinical practice, second edition. New York: Oxford University Press , 2001.

Lidz CW , Appelbaum PS , Meisel A. Two models of implementing informed consent . Arch Intern Med 1988; 148: 1383-1389 .

Levine RL. Ethics and regulation of clinical research, second edition. Baltimore, MD: Urban & Schwartzenberg , 1986.

Beauchamp TL , Childress JF. Principles of biomedical ethics, fourth edition. New York: Oxford University Press , 1994.

Lavori PW , Sugarman J , Hays MT , Feussner JR. Improving informed consent in clinical trials: a duty to experiment . Control Clin Trials 1999; 20: 187-193 .

Kaufman SR. The World War II plutonium experiments: contested stories and their lessons for medical research and informed consent . Culture Med Psychiatry 1997; 21: 161-197 .

Gray BH. Human subjects in medical experimentation: a sociological study of the conduct and regulation of research. New York: Wiley , 1975.

Cassileth BR , Zupkis RV , Sutton-Smith K , March V. Informed consent - why are its goals imperfectly realized ? N Engl J Med 1980; 302: 896-900 .

10.

Penman DT , Holland JC , Bahna GF et al. Informed consent for investigational chemotherapy: patients’ and physicians’ perceptions . J Clin Oncol 1984; 2: 849-855 .

11.

Tindall B , Forde S , Ross MW , Goldstein D , Barker S , Cooper DA. Effects of two formats of informed consent on knowledge among persons with advanced HIV disease in a clinical trial of didanosine . Patient Educ Counsel 1994; 24: 261-266 .

12.

Olver IN , Buchanan L , Laidlaw C , Poulton G. The adequacy of consent forms for informing patients entering oncological clinical trials . Ann Oncol 1995; 6: 867-870 .

13.

Cox K. Enhancing cancer clinical trial management: recommendations from a qualitative study of trial participants’ experiences . Psychooncology 2000; 9: 314-322 .

14.

Miller M. Phase I cancer trials: a collusion of misunderstanding . Hastings Cent Rep 2000; 4: 34-42 .

15.

Taylor KM , Kelner M. Informed consent: the physicians’ perspective . Soc Sci Med 1987; 24: 135-143 .

16.

Benson AB , Pregler JP , Bean JA , Rademaker AW , Eshler B , Anderson K. Oncologists’ reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study . J Clin Oncol 1991; 9: 2067-2075 .

17.

Mansour EG. Barriers to clinical trials. Part III: knowledge and attitudes of health care providers . Cancer 1994; 74 (Suppl): 2672-2676 .

18.

Joffe S , Cook EF , Cleary PD , Clark JW , Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey . Lancet 2001; 358: 1772-1777 .

19.

Kass NE , Sugarman J , Faden R , Schoch-Spana M. Trust: the fragile foundation of contemporary research . Hastings Cent Rep 1996; 26: 25-29 .

20.

Lowenberg JS. Interpretive research methodology: broadening the dialogue . ANS Adv Nurs Sci 1993; 16(2): 57-69 .

21.

Hammersley M , Atkinson P. Ethnography: principles in practice, second edition. London: Rout-ledge , 1995.

22.

Strauss A. Qualitative analysis for social scientists. Cambridge: Cambridge University Press , 1987.

23.

Sugarman J , McCrory DC , Powell D et al. Empirical research on informed consent: an annotated bibliography . Hastings Cent Rep 1999; (Suppl Jan-Feb): S1-S42 .

24.

Fox RC. Experiment perilous: forty-five years as a participant observer of patient-oriented clinical research . Perspect Biol Med 1996; 39: 206-226 .

25.

Feenberg A. On being a human subject: interest and obligation in the experimental treatment of incurable disease . Philos Forum 1992; XXIII: 213-230 .

26.

Epstein S. Impure science: AIDS, activism, and the politics of knowledge. Berkeley, CA: University of California Press , 1996.

27.

Cox K. Informed consent and decision-making: patients’ experiences of the process of recruitment to phases I and II anti-cancer drug trials . Patient Educ Counsel 2002; 46: 31-38 .

28.

Moore S. A need to try everything: patient participation in Phase I trials . J Adv Nurs 2001; 33: 738-747 .

29.

Mueller MR , Mamo L. Changes in medicine, changes in nursing: career contingencies and nurses in clinical trial co-ordination . Sociol Perspectives 2000; 43: S43-S57 .

30.

United States Department of Health and Human Services . Fact sheet: protecting the privacy of patients’ health information. Retrieved April 14, 2003, from: http://www.hhs.gov/news/facts/privacy.html